Globus Medical Inc (GMED): Congress and insider trades

Who in Congress and inside the company traded GMED, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Globus Medical Inc (GMED) is a listed stock on NYSE.
  • 4 members of Congress filed 6 buys and 7 sells of GMED, the latest published 2026-09-11 (11 September 2026).
  • Insiders filed 0 open market buys worth $0 and 2 sells worth $4.2M, the latest filed 2026-08-19 (19 August 2026).
  • Across 4 scored buys, Congress averaged -3.6% against the S&P 500 (SPY) over the 90 days after disclosure, with 50% of them ahead of the index. That result is too few trades to draw a conclusion.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 6 4 members
Congress sells 7
Insider buys 0 $0
Insider sells 2 $4.2M
Congress buys vs S&P, 90d -3.6% 4 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Congress trades in GMED

as of 2026-09-11
  1. Ro Khanna6 trades
  2. Josh Gottheimer4 trades
  3. Gil Cisneros2 trades
  4. Daniel S. Goldman1 trade
Congress trades in GMED, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
11 Sep 2026 Gil Cisneros (D-CA) buy 15K–50K 22 n/a
8 Apr 2026 Gil Cisneros (D-CA) buy 1K–15K 35 -26.5%
15 May 2025 Josh Gottheimer (D-NJ) sell 1K–15K 35 n/a
19 May 2023 Josh Gottheimer (D-NJ) buy 1K–15K 46 -7.9%
17 Apr 2023 Daniel S. Goldman (D-NY) sell 15K–50K 42 n/a
20 Mar 2023 Josh Gottheimer (D-NJ) sell 1K–15K 37 n/a
20 Feb 2023 Josh Gottheimer (D-NJ) sell 1K–15K 37 n/a
9 Sep 2022 Ro Khanna (D-CA) sell 1K–15K 16 n/a
11 Jul 2022 Ro Khanna (D-CA) sell 1K–15K 10 n/a
15 Jun 2022 Ro Khanna (D-CA) buy 1K–15K 18 +10.0%
15 Jun 2022 Ro Khanna (D-CA) buy 1K–15K 31 +10.0%
10 Jan 2022 Ro Khanna (D-CA) sell 1K–15K 24 n/a
8 Dec 2021 Ro Khanna (D-CA) buy 1K–15K 28 +10.1%

Insider trades in GMED

as of 2026-08-19
Open market insider trades in GMED, newest first.
FiledInsiderTypeSharesPriceValue90 day vs S&P
19 Aug 2026 ZARRILLI STEPHEN T sell 25,000 $87.04 $2.2M n/a
9 Jun 2026 Davidar David D sell 25,000 $80.76 $2.0M n/a

Frequently asked questions

Who has bought GMED?

6 Congress buys by 4 members and 0 insider buys are on file. The tables on this page list every one.

Did buying GMED after a disclosure beat the market?

Across 4 scored buys, Congress averaged -3.6% against the S&P 500 (SPY) over the 90 days after disclosure, with 50% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.